SCHEMBL26089125

SCHEMBL26089125

CSc1cc(C)ccc1P(=O)(c1ccccc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.47
▸ POLB P06746 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ HTT P42858 3/20 0.40
▸ KMT2A Q03164 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.37
▸ APOBEC3A P31941 1/20 0.36
▸ CASP6 P55212 1/20 0.36
▸ CTDSP1 Q9GZU7 1/20 0.36
▸ APOBEC3G Q9HC16 1/20 0.36
▸ HPGD P15428 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26087938 0.81 NPSR1 (0.43) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL14189073 0.77 POLB (0.59) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL26087623 0.77 POLB (0.48) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL4401114 0.77 POLB (0.50) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL18983243 0.76 HTT (0.50) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL26087274 0.75 KMT2A (0.51) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL4403134 0.71 POLB (0.47) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL23658864 0.71 HTT (0.39) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL25797354 0.71 HTT (0.39) MAPTPOLBKDM4EHTTKMT2A
SCHEMBL4403188 0.71 HPGD (0.61) MAPTPOLBKDM4EKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250136627-A1 Compound and Organic Light Emitting Device Comprising the Same LG CHEM, LTD. (KR) 2025-05-01 — — US disclosed
EP-4342902-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME LG Chem, Ltd. (KR) 2024-03-27 — — EP disclosed
CN-117529485-A Novel compound and organic light emitting device comprising the same 株式会社LG化学 2024-02-06 — — CN disclosed
WO-2023068824-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME 주식회사 엘지화학 2023-04-27 — — WO disclosed
WO-2023068824-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME 주식회사 엘지화학 2023-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250136627-A1 Compound and Organic Light Emitting Device Comprising the Same CRY1, CYP1A1, CRY2 MAPT 1124/4885POLB 2015/4885KDM4E 2899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback